Buying D-Wave Quantum Stock? 3 Things You Should Know First.

D-Wave remains a high-risk quantum computing pure play with highly lumpy revenue, including $15 million in Q1 2025 sales but only $4.1 million expected for Q1 2026. The company ended 2025 with $884 million in liquidity but also a $355 million loss, despite signing a $10 million Fortune 100 software deal and a $20 million Florida Atlantic University contract. Shares are extremely volatile, up 4,900% over three years but down 36% over the past six months, and the stock trades at a roughly 268 P/S ratio.

Analysis

QBTS is still in the classic pre-scale “optionality plus lumpy execution” phase: the equity is effectively pricing a long-duration call on quantum adoption while near-term fundamentals remain too small to stabilize the multiple. The second-order issue is that every hardware win creates noisy reported revenue, but it also lengthens the runway for software/consumables pull-through; if that attach rate improves, the market will start to value the installed base rather than the next deal. Until then, the stock remains hostage to single-contract timing and to whether the market continues to reward narrative over cash burn.

The key risk is not just losses, but dilution path dependency. With a premium valuation and heavy liquidity consumption, management has multiple ways to finance growth without near-term profitability, and each incremental capital raise or convert would likely be absorbed by a very wide investor base already positioned for the same story. That means good news can paradoxically cap upside if it arrives with another financing event, while bad news can create outsized gaps because there is no earnings cushion to absorb a miss.

The contrarian read is that the current setup may be less a fraud-on-the-future than a mispriced development-stage infrastructure asset with near-term reporting volatility. If the large enterprise and academic wins translate into a steadier pipeline over the next 2-4 quarters, the market could re-rate the name on backlog visibility and bookings quality rather than on quarterly revenue alone. But that re-rating likely requires proof of repeatable demand, not another isolated headline contract.

Competitively, the real beneficiaries of QBTS's volatility are not obvious public comps but the broader quantum ecosystem: cloud/service partners, systems integrators, and semiconductor equipment suppliers that monetize the buildout regardless of whether one vendor wins the platform race. For public-market positioning, the cleaner trade is to express skepticism through valuation compression rather than outright fundamental collapse, because the stock’s news sensitivity can still produce violent squeezes on any credible commercialization milestone.

Key Decisions for Investors

• Avoid initiating a standalone long QBTS here; the risk/reward is poor until there is evidence of 2-3 consecutive quarters of booking consistency. Reassess only after the next two prints if revenue becomes less dependent on single hardware events.
• For a tactical bearish expression, buy QBTS put spreads 1-2 quarters out, struck ~15-25% below spot, to target multiple compression while limiting premium risk. Best if entered after a post-rally strength day, not into a downside gap.
• If already long quantum as a theme basket, rotate exposure from QBTS into NVDA/INTC-linked infrastructure winners on any quantum headline spikes; QBTS remains the highest-beta, most dilution-sensitive way to own the theme.
• Use a pairs trade: short QBTS against a basket of AI/compute enablers (e.g., long NVDA or a semis ETF) over the next 3-6 months. The thesis is that near-term quantum enthusiasm is still too early relative to cash-generation, while compute infrastructure has visible earnings support.
• Set an alert around any financing or convert announcement; that would be the highest-probability catalyst for a sharp 20-40% drawdown and a better entry point for bearish structures.